刘 腾,段直光

视网膜静脉阻塞(retinal vein occlusion,RVO)，作为一组异质性疾病其发病机制复杂，是多因素作用的结果，其病变以视网膜静脉扩张迂曲、血流瘀滞、出血和水肿为特征。病程过程中常出现黄斑水肿（ME），其严重影响视功能，无特效的治疗方法，通常多种疗法相结合，治疗不及时会造成严重的视力威胁，影响患者的生活质量，所以探索对其更有效的治疗方法是非常必要和迫切的。

视网膜静脉阻塞；治疗；综述

[1] 眼科学/杨倍增，范先群主编.第9版.北京：人民卫生出版社，2018全国高等学校五年制本科临床医学专业第九轮规划教材ISBN 978-7-117-2667-3. [2] 孙梅,郝晓凤,谢立科,金琪,王诗惠,胥静.视网膜静脉阻塞动物模型的制作方法（英文）[J].国际眼科杂志,2020,20(11):1841-1846. [3] Cunha-Vaz J. The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture. Ophthalmologica.2017;237(1):1-10. [4] Daruich Alejandra,Matet Alexandre,Moulin Alexandre et al. Mechanisms of macular edema: Beyond the surface.[J] .Prog Retin Eye Res, 2018, 63:20-68. [5] Ferrara Napoleone,Damico Lisa,Shams Naveed et al. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.[J] .Retina, 2006,26:859-70. [6] 段直光,贾云琴,莫逆,陈银朝等.Bevacizumab治疗视网膜静脉阻塞继发黄斑水肿的临床观察[J].国际眼科杂志,2014,14(9):1594-1598. [7] 张淑锟.玻璃体腔内注射雷珠单抗辅助治疗新生血管性青光眼的效果分析[J].当代医药论丛,2020,18(12):71-72. [8] 陈丽莉,赵键.雷珠单抗治疗视网膜静脉阻塞合并黄斑水肿的疗效[J].中国临床医生杂志,2021,49(10):1246-1249. [9] Mishra S K,Gupta A,Patyal S et al. Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety.[J] .Int J Retina Vitreous, 2018, 4: 13. [10] Thakur Ashish,Kadam Rajendra,Kompella Uday B,Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts.[J] .Arch Ophthalmol, 2011, 129: 914-20. [11] Kwak H W,D'Amico D J,Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection.[J] .Arch Ophthalmol, 1992, 110: 259-66. [12] 方丽英,黄宝宇,黄敏丽.Ozurdex与康柏西普治疗视网膜静脉阻塞继发黄斑水肿的疗效对比[J].眼科新进展,2021,41(03):231-235. [13] Hattenbach Lars-Olof,Feltgen Nicolas,Bertelmann Thomas et al. Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B).[J] .Acta Ophthalmol, 2018, 96: e10-e18. [14] Chakravarthy Usha,Taylor Simon R,Koch Frank H Johannes et al. Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries.[J] .Br J Ophthalmol, 2019, 103: 1072-1077. [15] 刘彦，陈建华，赵慧英，吴香丽，殷英霞，陈冬军.康柏西普玻璃体腔注射联合激光光凝对糖尿病黄斑水肿患者脉络膜厚度的影响[J].陕西医学杂志,2019,48(08):1063-1073. [16] Hida Yoshifumi,Nakamura Shinsuke,Nishinaka Anri et al. Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model.[J] .J Pharmacol Sci, 2018, 137: 129-136. [17] Masayuki Hata,Hanako Ohashi Ikeda.Modulation of valosin-containing protein by Kyoto University Substances(KUS) as a novel therapeutic strategy for ischemic neuronal diseases[J].Neural Regeneration Research,2017,12(08):1252-1255. [18] Park Susanna S,Cell Therapy Applications for Retinal Vascular Diseases: Diabetic Retinopathy and Retinal Vein Occlusion.[J] .Invest Ophthalmol Vis Sci, 2016, 57: ORSFj1-ORSFj10. [19] Allingham Michael J,Tserentsoodol Nomingerel,Saloupis Peter et al. Aldosterone Exposure Causes Increased Retinal Edema and Severe Retinopathy Following Laser-Induced Retinal Vein Occlusion in Mice.[J] .Invest Ophthalmol Vis Sci, 2018, 59: 3355-3365. [20] Shirakata Yukari,Fukuda Kouki,Fujita Tomoyoshi et al. Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments.[J] .Clin Ophthalmol, 2016, 10: 277-83. [21] Opremcak E M,Bruce R A,Lomeo M D et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases.[J] .Retina, 2001, 21: 408-15. [22] Weiss J N,Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.[J] .Am J Ophthalmol, 1998, 126: 142-4. [23] 赵东贤,洪艳,王军.和血明目片联合视网膜激光光凝对视网膜静脉阻塞黄斑水肿患者的临床疗效[J].中成药,2021,43(06):1476-1480. [24] 谭明奎，肖紫云.通脉睛明汤联合康柏西普玻璃体腔注射治疗视网膜静脉阻塞继发黄斑水肿的疗效及对房水VEGF、bFGF、SDF-1的影响[J].药物流行病学杂志,2021,30(04):230-234. [25] 赵玉秋.血府逐瘀汤加减联合激光治疗视网膜静脉阻塞疗效观察[J].实用中医药杂志,2021,37(03): 378-370. [26] 潘存霞,张娜.眼底激光联合复方樟柳碱治疗视网膜分支静脉阻塞临床分析[J].中西医结合心血管病电子杂志,2020,8(35):67-70. [27] 黄江,邹维杰,季晓燕,等.抗血管内皮生长因子药物联合与不联合视网膜激光光凝治疗视网膜静脉阻塞合并黄斑水肿疗效比较的系统评价[J].中华眼底病杂志,2021,37(9):715-722.DOI:10. 3760/cma.j.cn511434-20210622-00334. [28] 王珏,王为农,张婕.阿柏西普联合激光光凝治疗视网膜中央静脉阻塞继发黄斑水肿的疗效分析[J].中国临床医生杂志,2020,48(09):1113-1116.

点击下载PDF